Journal of Allergy and Infectious Diseases

Commentary Open Access

Mitochondrial disease patients and rotavirus infection complications

Savannah Battleson, Anna Betler, Hayden Divers, Jack Kloecker, Iradukunda Esperance, Nicholas Farrell, Molly Sawyer, Azhar Rahama, Ojus Dalvi, Gary Vanderlaan

Rotavirus (RV) is an agent of gastroenteritis and, to a lesser extent, neurological manifestations including seizures and epilepsy. Before the development of effective vaccines, rotavirus was among the leading global drivers of life-threatening diarrhea in neonates and children less than five years of age.

J Allergy Infect Dis, 2024, Volume 5, Issue 1, p17-28 | DOI: 10.46439/allergy.5.042

Commentary Open Access

Monitoring clinical trials in infectious diseases

David L DeMets, PhD, Thomas R Fleming, PhD, Susan S Ellenberg, PhD

In early 2020, the contagious and deadly virus, SARS-CoV-2, was identified. The virus spread rapidly worldwide and was declared a pandemic by the World Health Organization (WHO) in March of 2020 [1]. While many who became infected remained asymptomatic, an alarming number of infected individuals developed severe symptoms, often requiring hospitalization and intensive care, or resulting in death.

J Allergy Infect Dis, 2021, Volume 2, Issue 1, p29-32 | DOI: 10.46439/allergy.2.019

Commentary Open Access

Policy and law changes to address healthcare inequities for minority populations during COVID-19

Christina M. Williams, Rahul Chaturvedi, Rodney A. Gabriel

While other countries have begun to see a flattening of the Severe Acute Respiratory Syndrome – Coronavirus-2 (SARS-CoV-2) curve, the United States continues to see a rise in cases, with approximately 7.4 million confirmed cases to date. Even more worrisome, various news articles have begun to shed light on the healthcare inequities that have become increasingly more transparent during this crisis.

J Allergy Infect Dis, 2020, Volume 1, Issue 3, p49-52 | DOI: 10.46439/allergy.1.011